1-(2-fluoroethyl)-3-(4-fluorophenyl)-4-(3-oxo-4H-1,4-benzoxazin-6-yl)pyrrole-2,5-dione
C20H14F2N2O4 — CID 89142442
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(2-fluoroethyl)-3-(4-fluorophenyl)-4-(3-oxo-4H-1,4-benzoxazin-6-yl)pyrrole-2,5-dione
1-(2-fluoroethyl)-3-(4-fluorophenyl)-4-(3-oxo-4H-1,4-benzoxazin-6-yl)pyrrole-2,5-dione (PubChem CID 89142442) has the molecular formula C20H14F2N2O4 and a molecular weight of 384.34 g/mol. Its IUPAC name is 1-(2-fluoroethyl)-3-(4-fluorophenyl)-4-(3-oxo-4H-1,4-benzoxazin-6-yl)pyrrole-2,5-dione.
Molecular Properties
| Compound Name | 1-(2-fluoroethyl)-3-(4-fluorophenyl)-4-(3-oxo-4H-1,4-benzoxazin-6-yl)pyrrole-2,5-dione |
|---|---|
| PubChem CID | 89142442 |
| Molecular Formula | C20H14F2N2O4 |
| Molecular Weight | 384.34 g/mol |
| Exact Mass | 384.09 |
| IUPAC Name | 1-(2-fluoroethyl)-3-(4-fluorophenyl)-4-(3-oxo-4H-1,4-benzoxazin-6-yl)pyrrole-2,5-dione |
| SMILES | O=C1COc2ccc(C3=C(c4ccc(F)cc4)C(=O)N(CCF)C3=O)cc2N1 |
| InChI | InChI=1S/C20H14F2N2O4/c21-7-8-24-19(26)17(11-1-4-13(22)5-2-11)18(20(24)27)12-3-6-15-14(9-12)23-16(25)10-28-15/h1-6,9H,7-8,10H2,(H,23,25) |
| InChIKey | UYBSWAPZIFDWCM-UHFFFAOYSA-N |
| XLogP | 2.41 |
| TPSA | 75.71 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 384.34 |
| LogP ≤ 5 | 2.41 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'}, {'alert_name': 'stilbene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 89142442 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.